Company news

Fulcrum Therapeutics, Inc. news in 2025

Fulcrum Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants

December 9, 2025

Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock

December 7, 2025

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

December 5, 2025

Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025

December 1, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

November 2, 2025

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025

October 28, 2025

Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8: 00 a.m. ET

October 21, 2025

Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025

October 13, 2025

Fulcrum Therapeutics to Present at Upcoming Investor Meetings

August 25, 2025

Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

July 29, 2025

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025

July 28, 2025

Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

July 27, 2025

Fulcrum Therapeutics to Present at Upcoming Medical Meetings

May 28, 2025

Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

May 28, 2025

Fulcrum Therapeutics to Participate in Upcoming May Conferences

May 7, 2025

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025

April 30, 2025

Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8: 00 a.m. ET

April 23, 2025

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

March 3, 2025

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024

February 24, 2025

Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8: 00 a.m. ET

February 17, 2025

Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

February 5, 2025

Calls in 2025

Decks in 2025